Does Companhia Brasileira De Distribuicao (CBD) Have A Risk Factor?

The stock of Companhia Brasileira De Distribuicao (NYSE:CBD) decreased by -$0.15 on Tuesday to finish at $1.10, down -12.00 percent. The last five days have seen an average of 2,881,480 shares of common stock traded. 18 times new highs were reached in the current year, with a fall of -$2.00. The average number of shares traded over the last 20 days was 1,475,190, while the average volume over the last 50 days totaled 1,333,620.

CBD stock dropped -18.89% since last month. On 08/29/23, the company’s shares reached a one-month low of $1.04. The stock touched a high of $1.49 on 07/12/23, after rallying from a low of $0.79 in 52 weeks. The price of CBD stock has risen by 13.55% or -$2.00 this year, reaching a new high 18 times. Still, the stock price is down -26.05% from the 52-week high.

Valuation Metrics

Beta for the stock is 1.35. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.03, the price-to-book (PB) ratio of 0.11.

Company paid $0.0610 per share in dividends, a decrease of -84.74% from $0.3997 last year.

Financial Health

For the three months ended September 29, Companhia Brasileira De Distribuicao’s quick ratio was 1.50, while its current ratio was 1.60, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending September 29 is 0.64, and the total debt to equity ratio is 0.80. As far as profitability goes, gross margin for the trailing twelve months is 23.90% percent. Based on annual data, it had gross profit of $833.3 million and revenue of $3.36 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. There was a -0.50% return on investment (ROI) in the past year.

Earnings Surprise

According to Companhia Brasileira De Distribuicao’s quarterly financial report for the quarter that ended September 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $3.29 billion, while revenues fell by -1457.37% to $0.0. It was predicted that Companhia Brasileira De Distribuicao’s quarterly earnings would be -$0.21, but it ended up being -$0.18, beating the consensus by -16.70%. EBITDA was $55.38 million for the quarter. At the end of Companhia Brasileira De Distribuicao’s most recent quarter ended September 29, its liabilities totaled 6.2 billion, while its total debt was $11.07 billion.

Technical Picture

Here’s a quick look at Companhia Brasileira De Distribuicao’s (CBD) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 9.58%, suggesting the stock is oversold, with a 637.90% historical volatility rate.

The stochastic %K and %D were 15.87% and 30.29% respectively, while the average true range (ATR) was 0.50. Based on the 14-day stochastic reading of 1.76%, the RSI (14) reading is 13.18%. On the 9-day MACD Oscillator, the stock is at -0.70, and the 14-day reading is at -0.81.

Analyst Ratings

Companhia Brasileira De Distribuicao (NYSE: CBD) was downgraded by BofA Securities to a an Underperform rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Companhia Brasileira De Distribuicao (CBD) an Hold rating. CBD is a stock that is recommended for selling by 0 brokerage firms, while 5 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.

What is CBD’s price target for the next 12 months?

The current consensus forecast for the stock is between $2.66 and $5.21, with a median target price of $4.25. In analyzing these forecasts, the average price target given by analysts for Companhia Brasileira De Distribuicao (CBD) is $4.02.

Most Popular

Related Posts